small biotech
Biotech Outlook 2013: Top Biotechs Infographic
September 24 by Pharmaceuticals & Biotechnology Editor
“Biotech industry growth is bolstered by increased R&D spending, an upswing of approved first-in-class medicines, elevated Wall Street valuations, and continued forging of pipeline allian...
OpEx for 2013 – Crystal Ball Predictions
March 08 by Jon WetzelTo look forward we need to first look back. From 2008-2012 we saw big pharma collide creating larger companies. Genentech-Roche, Novartis-Alcon, Pfizer-Wyeth and GlaxoSmithKline-Human Ge...
